GeneReach Biotechnology (ROCO:4171) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4171 GeneReach Biotechnology Corp ROCO:4171
60 GF Score
Price NT$18.45
GF Value NT$23.98
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is GeneReach Biotechnology Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ROCO:4171 vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, GeneReach Biotechnology's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeneReach Biotechnology Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeneReach Biotechnology's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where GeneReach Biotechnology's Short Percentage of Float falls into.


ROCO:4171
60GF Score
GeneReach Biotechnology Corp ROCO:4171
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GeneReach Biotechnology (ROCO:4171) Overvalued in 2026?

Based on GuruFocus' analysis, GeneReach Biotechnology stock appears to be undervalued. The current stock price of NT$18.45 is trading 23.1% below its estimated GF Value™ of NT$23.98. GuruFocus considers GeneReach Biotechnology to be Modestly Undervalued.

Key valuation signals for ROCO:4171:

  • Short Percentage of Float:
  • GF Value™: NT$23.98 vs. price of NT$18.45 (23.1% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4171 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GeneReach Biotechnology Business Description

Address No.19, Keyuan 2nd Road, Taichung, TWN, 407
GeneReach Biotechnology Corp is a biotechnology company. The company develops, manufactures and markets products for applied nucleic acid detection technology. Its products are utilised for aquaculture, agriculture, food, companion animal, livestock and human health industries.
60GF Score

Get the complete analysis for ROCO:4171

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.45
Price
NT$23.98
GF Value